| Trial ID: | L4682 |
| Source ID: | NCT00208221
|
| Associated Drug: |
Ramipril
|
| Title: |
Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypertension|Type 2 Diabetes|Albuminuria
|
| Interventions: |
DRUG: ramipril|DRUG: ramipril-telmisartan
|
| Outcome Measures: |
Primary: Microalbuminuria | Secondary: Plasma renin|plasma angiotensin|plasma aldosterone|plasma catecholamines|oxydative stress|diastolic blood pressure|systolic blood pressure
|
| Sponsor/Collaborators: |
Sponsor: Institut de Recherches Cliniques de Montreal
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
2007-06
|
| Results First Posted: |
|
| Last Update Posted: |
2007-11-08
|
| Locations: |
Institut de Recherches Cliniques de Montreal, Montreal, Quebec, J4X 1J3, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00208221
|
